​

Ardelyx (ARDX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ARDX Stock Forecast

Ardelyx (ARDX) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $9.50, with a high of $11.00 and a low of $8.00. This represents a 73.36% increase from the last price of $5.48.

$5 $6 $7 $8 $9 $10 $11 High: $11 Avg: $9.5 Low: $8 Last Closed Price: $5.48

ARDX Stock Rating

Ardelyx stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 1 7 Strong Sell Sell Hold Buy Strong Buy

ARDX Forecast vs Benchmarks

TypeNameUpside
StockArdelyx73.36%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts114
Avg Price Target$8.00$8.00$11.00
Last Closing Price$5.48$5.48$5.48
Upside/Downside45.99%45.99%100.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-83--11
Dec, 24-82--10
Nov, 24582--15
Oct, 24781--16
Sep, 24781--16
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 02, 2025Dennis DingJefferies$8.00$5.1256.25%45.99%
Aug 05, 2024Ed ArceH.C. Wainwright$11.00$6.0581.82%100.73%
Jul 05, 2024Ed ArceH.C. Wainwright$10.00$5.2989.04%82.48%
May 24, 2024Christopher RaymondRaymond James$15.00$7.20108.33%173.72%
Dec 18, 2023Ryan DeschnerRaymond James$12.00$6.3190.17%118.98%
Dec 30, 2022Citigroup$7.00$2.85145.61%27.74%
Dec 29, 2022Laura ChicoWedbush$2.00$2.34-14.53%-63.50%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 02, 2025JefferiesBuyBuyhold
Aug 05, 2024H.C. WainwrightBuyBuyhold
Aug 02, 2024WedbushBuyBuyhold
Jul 05, 2024H.C. WainwrightBuyBuyhold
Jul 02, 2024Piper SandlerOverweightNeutraldowngrade
Jun 20, 2024WedbushBuyBuyhold
May 24, 2024Piper SandlerOverweightOverweighthold
May 24, 2024WedbushBuyBuyhold
May 03, 2024Cowen & Co.BuyBuyhold
May 03, 2024CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.05$-1.52$-0.42$-0.30-----
Avg Forecast$-1.00$-1.51$-0.51$-0.27$-0.17$-0.14$0.40$0.84$1.21
High Forecast$-1.26$-1.92$-0.70$-0.30$-0.23$-0.45$0.04$0.47$1.03
Low Forecast$-0.77$-1.17$-0.39$-0.21$-0.12$0.38$0.93$1.34$1.52
Surprise %5.00%0.66%-17.65%11.11%-----

Revenue Forecast

$0 $200M $400M $600M $800M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.57M$10.10M$52.16M$124.46M-----
Avg Forecast$6.92M$9.75M$34.15M$124.20M$327.18M$374.66M$503.68M$650.81M$797.50M
High Forecast$5.71M$8.04M$28.01M$122.28M$314.26M$342.01M$495.00M$631.79M$704.65M
Low Forecast$8.34M$11.74M$44.16M$127.81M$341.44M$410.26M$512.36M$669.84M$952.97M
Surprise %9.36%3.56%52.74%0.20%-----

Net Income Forecast

$-300M $-170M $-40M $90M $220M $350M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-94.31M$-158.16M$-67.21M$-66.07M-----
Avg Forecast$-219.06M$-135.94M$-138.92M$-66.07M$-38.82M$-45.84M$83.22M$207.57M$265.76M
High Forecast$-277.26M$-163.13M$-166.71M$-79.28M$-51.03M$-98.10M$8.18M$103.80M$225.54M
Low Forecast$-169.11M$-108.75M$-111.14M$-52.85M$-26.62M$83.49M$204.48M$294.88M$333.11M
Surprise %-56.95%16.35%-51.62%0.00%-----

ARDX Forecast FAQ

Is Ardelyx stock a buy?

Ardelyx stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Ardelyx is a favorable investment for most analysts.

What is Ardelyx's price target?

Ardelyx's price target, set by 8 Wall Street analysts, averages $9.5 over the next 12 months. The price target range spans from $8 at the low end to $11 at the high end, suggesting a potential 73.36% change from the previous close price of $5.48.

How does Ardelyx stock forecast compare to the average forecast of its sector, industry, and investment themes?

Ardelyx stock forecast shows a 73.36% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Ardelyx over the past three months?

  • January 2025: 0% Strong Buy, 72.73% Buy, 27.27% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 33.33% Strong Buy, 53.33% Buy, 13.33% Hold, 0% Sell, 0% Strong Sell.

What is Ardelyx’s EPS forecast?

Ardelyx's average annual EPS forecast for its fiscal year ending in December is -0.17 for 2024, a -43.33% decrease from the reported $-0.3 in 2023. The prediction for 2025 is $-0.14, $0.4 for 2026, $0.84 for 2027, and $1.21 for 2028.

What is Ardelyx’s revenue forecast?

Ardelyx's average annual revenue forecast for its fiscal year ending in December is $327.18M for 2024, a 162.89% increase from the reported $124.46M in 2023. The forecast for 2025 is $374.66M, $503.68M for 2026, $650.81M for 2027, and $797.5M for 2028.

What is Ardelyx’s net income forecast?

For its fiscal year ending in December, Ardelyx's average annual net income forecast is $-38.824M for 2024, reflecting a -41.24% decrease from the reported $-66.067M in 2023. The projection for 2025 is $-45.835M, $83.22M for 2026, $207.57M for 2027, and $265.76M for 2028.